These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3624373)

  • 1. Analysis of formulations containing pralidoxime mesylate by liquid chromatography.
    Utley D
    J Chromatogr; 1987 Jun; 396():237-50. PubMed ID: 3624373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pralidoxime chloride stability-indicating assay and analysis of solution samples stored at room temperature for ten years.
    Schroeder AC; DiGiovanni JH; Von Bredow J; Heiffer MH
    J Pharm Sci; 1989 Feb; 78(2):132-6. PubMed ID: 2715935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation pathway of pralidoxime chloride in concentrated acidic solution.
    Fyhr P; Brodin A; Ernerot L; Lindquist J
    J Pharm Sci; 1986 Jun; 75(6):608-11. PubMed ID: 3735107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of pralidoxime chloride and its major decomposition products in injectable solutions.
    Prue DG; Johnson RN; Kho BT
    J Pharm Sci; 1983 Jul; 72(7):751-6. PubMed ID: 6886980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of 2-hydroxyiminomethyl-N-methylpyridinium ion in plasma and aqueous humor as indices of the toxicity of pralidoxime mesylate (P2S) for the rabbit.
    Ballantyne B; Gazzard MF; Robson DC; Swanston DW
    Toxicol Appl Pharmacol; 1975 Sep; 33(3):559-67. PubMed ID: 1188951
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiometric investigation of the stability of palladium(II) complex of pralidoxime chloride in aqueous solution.
    Karljiković-Rajić K; Stanković B
    J Pharm Biomed Anal; 1990; 8(8-12):705-9. PubMed ID: 2100611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of UV spectroscopic, chromatographic, and electrophoretic methods for the cholinesterase reactivating antidote pralidoxime (2-PAM).
    John H; Blum MM
    Drug Test Anal; 2012; 4(3-4):179-93. PubMed ID: 21953823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures.
    Holland P; Parkes DC; White RG
    Br J Clin Pharmacol; 1975 Aug; 2(4):333-8. PubMed ID: 788732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pralidoxime mesylate on the measurement of cyanide concentrations in solutions.
    Ballantyne B
    Vet Hum Toxicol; 1984; 26 Suppl 2():23-7. PubMed ID: 6523723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrophotometric investigation of complex formation of an oxime PAM-4Cl with palladium (II) and its analytical application.
    Karljiković-Rajić K; Stanković B; Granov A
    J Pharm Biomed Anal; 1990; 8(8-12):735-8. PubMed ID: 2100615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of pralidoxime chloride in pharmaceutical dosage forms by isotachophoresis.
    Bodiroga M; Agbaba D; Zivanov-Stakic D; Popovic R
    J Pharm Biomed Anal; 1994 Jan; 12(1):127-9. PubMed ID: 8161599
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of the oxime Pralidoxime Mesylate (P2S) after repeated oral and intramuscular administration.
    Holland P; Parkes DC
    Br J Ind Med; 1976 Feb; 33(1):43-6. PubMed ID: 1268107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of hydroxylamine and cyanide in formulations containing pralidoxime salts by flow injection.
    Utley D
    Analyst; 1990 Sep; 115(9):1239-42. PubMed ID: 2091493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion-exclusion chromatography of compounds of biological interest.
    Crone HD
    J Chromatogr; 1975 Apr; 107(1):25-33. PubMed ID: 237935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a reverse phase liquid chromatography method for the simultaneous quantification of eserine and pralidoxime chloride in drugs-in-adhesive matrix type transdermal patches.
    Banerjee S; Chattopadhyay P; Ghosh A; Kaity S; Veer V
    Drug Res (Stuttg); 2013 Sep; 63(9):450-6. PubMed ID: 23633237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicity of 2-hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S).
    DAVIES DR; WILLEY GL
    Br J Pharmacol Chemother; 1958 Jun; 13(2):202-6. PubMed ID: 13536287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobehavioral effects of pralidoxime mesylate in the rat.
    Liu WF; Beaton JM
    Neurobehav Toxicol Teratol; 1985; 7(5):449-52. PubMed ID: 4080064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) on rat intestinal, (Na-K)ATPase and adenyl cyclase activities.
    Laufer J; Karmeli F; Rachmilewitz D; Scapa E
    Eur J Pharmacol; 1981 Aug; 74(1):61-6. PubMed ID: 6274651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of atropine in the presence of pralidoxime chloride.
    Lindén E; Schill G
    Acta Pharm Suec; 1967 Dec; 4(6):327-34. PubMed ID: 5589691
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of N-methylpyridinium 2-aldoxime methylsulfate (Contrathion) in rat plasma and urine by high-performance copper(II)--silica ligand-exchange chromatography.
    Guyon F; Tambute A; Caude M; Rosset R
    J Chromatogr; 1982 May; 229(2):475-80. PubMed ID: 7096486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.